Avacta (AVCT)

Avacta Group plc is engaged in healthcare equipment and instrumentation business, provides technologies and services to the life sciences/healthcare sector through two operating divisions: Avacta Analytical and Avacta Animal Health. Avacta Analytical provides analytical instrumentation and services to the biopharmaceutical sector. Its analytical instrument, Optim, is distributed through Pall Corporation in the United States, Isogen Life Sciences in Europe, Cold Spring Biotech Corp in the People’s Republic of China and Taiwan and DKSH in Japan. Avacta sells Optim directly in the United Kingdom. Avacta Animal Health provides diagnostic products and services. It equips veterinary professionals with animal health information, through point of care diagnostics, reagents and testing kits and laboratory based testing. Avacta’s AX-1 point of care immunoassay system is focused at providing the veterinarian with blood test results in the clinic.

Directors: Alastair Smith (CEO) , Timothy Sykes (CFO) ,

No. of Employees: 64 No. of Shareholders: n/a

Last Annual	July 31st, 2012
Last Interim	January 31st, 2013
Shares in Issue	3,156,844,912
Free Float	879.0m (27.8%)

Sector	Healthcare
Industry	Healthcare Equipment & Supplies
Index	FTSE Aim All Share,
Exchange	London Stock Exchange (AIM)
Eligible for	an ISA? a SIPP?